HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro.

AbstractBACKGROUND:
Bartonella henselae is a Gram-negative bacterium transmitted to humans by a scratch from cat in the presence of ectoparasites. Humans infected with B. henselae can result in various clinical diseases including local lymphadenopathy and more serious systemic disease such as persistent bacteremia and endocarditis. The current treatment of persistent B. henselae infections is not very effective and remains a challenge. To find more effective treatments for persistent and biofilm Bartonella infections, in this study, we evaluated a panel of drugs and drug combinations based on the current treatment and also promising hits identified from a recent drug screen against stationary phase and biofilm recovered cells of B. henselae.
RESULTS:
We evaluated 14 antibiotics and 25 antibiotic combinations for activity against stationary phase B. henselae (all antibiotics were at 5 μg/ml) and found that ciprofloxacin, gentamicin, and nitrofurantoin were the most active agents, while clofazimine and miconazole had poor activity. Drug combinations azithromycin/ciprofloxacin, azithromycin/methylene blue, rifampin/ciprofloxacin, and rifampin/methylene blue could rapidly kill stationary phase B. henselae with no detectable CFU after 1-day exposure. Methylene blue and rifampin were the most active agents against the biofilm B. henselae after 6 days of drug exposure. Antibiotic combinations (azithromycin/ciprofloxacin, azithromycin/methylene blue, rifampin/ciprofloxacin, rifampin/methylene blue) completely eradicated the biofilm B. henselae after treatment for 6 days.
CONCLUSIONS:
These findings may facilitate development of more effective treatment of persistent Bartonella infections in the future.
AuthorsXiaoyan Zheng, Xiao Ma, Tingting Li, Wanliang Shi, Ying Zhang
JournalBMC microbiology (BMC Microbiol) Vol. 20 Issue 1 Pg. 87 (04 10 2020) ISSN: 1471-2180 [Electronic] England
PMID32276590 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics
  • Drug Combinations
  • Gentamicins
  • Ciprofloxacin
  • Azithromycin
  • Nitrofurantoin
  • Methylene Blue
  • Rifampin
Topics
  • Analgesics (pharmacology)
  • Azithromycin (pharmacology)
  • Bartonella henselae (drug effects, physiology)
  • Biofilms (drug effects)
  • Ciprofloxacin (pharmacology)
  • Drug Combinations
  • Drug Therapy, Combination
  • Gentamicins (pharmacology)
  • Methylene Blue (pharmacology)
  • Microbial Sensitivity Tests
  • Microbial Viability (drug effects)
  • Nitrofurantoin (pharmacology)
  • Rifampin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: